Zobrazeno 1 - 1
of 1
pro vyhledávání: '"D. Negrão Gonçalo Dias"'
Autor:
D. Negrão Gonçalo Dias, D. Titton, R. Xavier, G.da R.C. Pinheiro, M. Pinheiro, Ieda Maria Magalhães Laurindo, L. Balarini, José Caetano Macieira, Fabiana Pompeo de Pina, Manoel Barros Bertolo, M. Ohira Gazzeta, Markus Bredemeier, Cristiano Michelini Lupo, Roberto Ranza, Valeria Valim, P. Louzada, A. Maria Kakehasi, Lívia G. Rocha, Claiton Viegas Brenol, Vander Fernandes, Maria de Fátima Lobato da Cunha Sauma, S. Studart, R Botelho, Hellen M.S. Carvalho, Ana Paula Medeiros, Ivânio Alves Pereira, Gláucio Ricardo Werner de Castro, Inês Guimarães da Silveira, João Luiz de Miranda, Aline Ranzolin, B. Stadler, Sergio Kowalski, A. Duarte, André Luiz Shinji Hayata, R. Chakr
Publikováno v:
Annals of the Rheumatic Diseases. 80:582.2-583
Background:After failure of conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs) in the therapy of rheumatoid arthritis (RA), treatment may be escalated to biologic (bDMARDs) or JAK inhibitors (JAKi) (1). Analysis of drug survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80ede3938828b2943eb873edc00b27b9
https://doi.org/10.1136/annrheumdis-2021-eular.3841
https://doi.org/10.1136/annrheumdis-2021-eular.3841
